A leading investment bank and investment fund headquartered in China is currently interested in investing in privately held companies in the Healthcare sector. The firm currently manages two funds, one of which only invests in China, and another early-stage fund that focuses on investments into US start-ups. The firm is planning to raise a second and much larger US fund in next 12 months. On average, the initial size of investment is in the $2-3M range.
The firm is a flexible and opportunistic investor that is currently considering Therapeutics, Medical Devices, Diagnostics, genomics, healthcare services and healthcare IT companies. With respect to medical devices, the firm is interested in devices with all FDA regulatory pathways, including 510k, PMA, and software-enabled devices.
The firm prefers to act as the lead investor but is also open to co-investing. The firm will neither seek a board seat nor seek distribution rights.
If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.
Next Phase Newsletter 
Leave a Reply